RPE tears after pegaptanib treatment in age-related macular degeneration

Retina

Volumn 27, Issue 7, 2007, Pages 857-863

  Chang, Louis K ^a   Flaxel, Christina J ^b   Lauer, Andreas K ^b   Sarraf, David ^a,c,d,e  

^a JULES STEIN EYE INSTITUTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Kaiser Permanente ^*  (United States)

^d KING DREW MEDICAL CENTER   (United States)

^e Greater la VA Healthcare Centre   (United States)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Pegaptanib; Pigment epithelial detachment; Retinal pigment epithelium tear; Vascular endothelial growth factor

Indexed keywords

PEGAPTANIB;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; HYPERREFLECTIVE RETINAL PIGMENT EPITHELIUM; MALE; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; RETINA TEAR; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; APTAMERS, NUCLEOTIDE; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; PIGMENT EPITHELIUM OF EYE; POSTOPERATIVE COMPLICATIONS; RETINAL PERFORATIONS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 34250210397     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3180342c42     Document Type: Article

References (25)

1. Witmer AN, Vrensen GFJM, Van Noorden CJF, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Progr Retin Eye Res 2003;22:1-29.
2. Gragoudas ES, Adamis AP, Cunningham ET, et al. VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-2816.
3. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in Photodynamic Therapy report 2. Am J Ophthalmol 2001;131:541-560.
4. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP), Verteporfin in Photodynamic Therapy Study Groups. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials - TAP and VIP Report No. 3. Am J Ophthalmol 2004;137:683-696.
5. Dhalla MD, Blinder KJ, Tewari A, et al. Retinal epithelial pigment tear following intravitreal pegaptanib sodium. Am J Ophthalmol 2006;141:751-753.
6. Singh RP, Sears JE. Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol 2006;142:160-162.
7. Meyer CH, Mennel S, Schmidt JC, Kroll P. Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration. Br J Ophthalmol 2006;90:1207-1208.
8. Coscas G, Koenig F, Soubrane G. The pretear characteristics of pigment epithelial detachments. Arch Ophthalmol 1990;108:1687-1693.
9. Goldstein BG, Pavan PR. "Blow-outs" in the retinal pigment epithelium. Br J Ophthalmol 1987;71:676-681.
10. Ishida Y, Kato T, Minamoto A, et al. Retinal pigment epithelial tear in a patient with central serous chorioretinopathy treated with corticosteroids. Retina 2004;24:633-636.
11. Lim JI, Lam S. A retinal pigment epithelium tear in a patient with angioid streaks. Arch Ophthalmol 1990;109:1672-1674.
12. Jogiya A, Newsom RSB. Giant retinal pigment epithelium rip secondary to subretinal proliferative vitreoretinopathy. Eye 2004;18:960-962.
13. Hoskin A, Bird AC, Sehmi K. Tears of detached retinal pigment epithelium. Br J Ophthalmol 1981;65:417-422.
14. Gass JDM. Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol 1984;98:700-706.
15. Gelisken F, Indhofen W, Partsch M, et al. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 2001;131:518-520.
16. Pece A, Introini U, Bottoni F, et al. Acute retinal pigment epithelial tear after photodynamic therapy. Retina 2001;21:661-665.
17. Goldstein M, Heilweil G, Barak A, Loewenstein A. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye 2005;19:1315-1324.
18. Casswell AG, Kohen D, Bird AC. Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 1985;69:397-403.
19. Hee MR, Bausmal CR, Puliafito CA, et al. Optical coherence tomography in age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996;103:1260-1270.
20. Giovannini A, Amato G, Mariotti C, Scassellati-Sforzolini B. Optical coherence tomography in the assessment of retinal pigment epithelial tear. Retina 2000;20:37-40.
21. Bressler NM, Finklestein D, Sunness JS, et al. Retinal pigment epithelial tears through the fovea with preservation of good visual acuity. Arch Ophthalmol 1990;108:1694-1697.
22. Jaeger RD, Aiello LP, Patel SC, Cunningham ET. Risks of intravitreous injection: a comprehensive review. Retina 2004;24:676-698.
23. Chuang EL, Bird AC. The pathogenesis of tears of the retinal pigment epithelium. Am J Ophthalmol 1988;105:285-290.
24. Gass JDM. Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol 1984;68:513-519.
25. Chuang EL, Bird AC. Bilaterality of tears of the retinal pigment epithelium. Br J Ophthalmol 1988;72:918-920.